20/20 Biolabs says Vermont selects OneTest for firefighter cancer screening, sees about $500,000 revenue from first cohort
Share
Listen to the news
20/20 Biolabs says Vermont selects OneTest for firefighter cancer screening, sees about $500,000 revenue from first cohort
  • 20/20 Biolabs won a Vermont firefighter cancer-screening contract for its OneTest multi-cancer blood test, covering up to 4,500 firefighters.
  • First cohort testing through end-2026 targets about one-third of eligible firefighters, expected to generate about $500,000 in testing revenue.
  • Contract includes options for Vermont to renew for up to two additional 12-month periods.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 20/20 Biolabs Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605270831PRIMZONEFULLFEED9727096) on May 27, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending